WallStSmart

The Clorox Company (CLX)vsProcter & Gamble Company (PG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Procter & Gamble Company generates 1183% more annual revenue ($86.72B vs $6.76B). PG leads profitability with a 19.2% profit margin vs 11.2%. CLX appears more attractively valued with a PEG of 2.20. PG earns a higher WallStSmart Score of 61/100 (C+).

CLX

Buy

57

out of 100

Grade: C

Growth: 3.3Profit: 8.0Value: 4.7Quality: 6.5
Piotroski: 5/9Altman Z: 2.07

PG

Buy

61

out of 100

Grade: C+

Growth: 5.3Profit: 8.5Value: 3.3Quality: 6.0
Piotroski: 4/9Altman Z: 3.01
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CLXSignificantly Overvalued (-22.9%)

Margin of Safety

-22.9%

Fair Value

$102.51

Current Price

$94.14

$8.37 premium

UndervaluedFair: $102.51Overvalued
PGSignificantly Overvalued (-46.4%)

Margin of Safety

-46.4%

Fair Value

$99.13

Current Price

$146.54

$47.41 premium

UndervaluedFair: $99.13Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CLX3 strengths · Avg: 9.3/10
Return on EquityProfitability
54.6%10/10

Every $100 of equity generates 55 in profit

Debt/EquityHealth
-66.9610/10

Conservative balance sheet, low leverage

P/E RatioValuation
15.7x8/10

Attractively priced relative to earnings

PG5 strengths · Avg: 9.2/10
Market CapQuality
$326.66B10/10

Mega-cap, among the largest globally

Return on EquityProfitability
30.6%10/10

Every $100 of equity generates 31 in profit

Altman Z-ScoreHealth
3.0110/10

Safe zone — low bankruptcy risk

Operating MarginProfitability
23.1%8/10

Strong operational efficiency at 23.1%

Free Cash FlowQuality
$3.03B8/10

Generating 3.0B in free cash flow

Areas to Watch

CLX4 concerns · Avg: 3.5/10
PEG RatioValuation
2.204/10

Expensive relative to growth rate

Revenue GrowthGrowth
0.1%4/10

0.1% revenue growth

EPS GrowthGrowth
2.7%4/10

2.7% earnings growth

Free Cash FlowQuality
$-165.00M2/10

Negative free cash flow — burning cash

PG1 concerns · Avg: 2.0/10
PEG RatioValuation
3.942/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : CLX

The strongest argument for CLX centers on Return on Equity, Debt/Equity, P/E Ratio.

Bull Case : PG

The strongest argument for PG centers on Market Cap, Return on Equity, Altman Z-Score. Profitability is solid with margins at 19.2% and operating margin at 23.1%.

Bear Case : CLX

The primary concerns for CLX are PEG Ratio, Revenue Growth, EPS Growth.

Bear Case : PG

The primary concerns for PG are PEG Ratio.

Key Dynamics to Monitor

CLX profiles as a value stock while PG is a mature play — different risk/reward profiles.

CLX carries more volatility with a beta of 0.55 — expect wider price swings.

PG is growing revenue faster at 7.4% — sustainability is the question.

PG generates stronger free cash flow (3.0B), providing more financial flexibility.

Bottom Line

PG scores higher overall (61/100 vs 57/100), backed by strong 19.2% margins. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

The Clorox Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

The Clorox Company, based in Oakland, California, is an American global manufacturer and marketer of consumer and professional products.

Procter & Gamble Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

The Procter & Gamble Company (P&G) is an American multinational consumer goods corporation headquartered in Cincinnati, Ohio, founded in 1837 by William Procter and James Gamble. It specializes in a wide range of personal health, consumer health, personal care, and hygiene products; these products are organized into several segments including Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine, & Family Care. Before the sale of Pringles to Kellogg's, its product portfolio also included food, snacks, and beverages.

Visit Website →

Want to dig deeper into these stocks?